First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 182.1 USD 0.97% Market Closed
Updated: Mar 29, 2024

Abbvie Inc
Cash Equivalents

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
|

Abbvie Inc
Cash Equivalents Peer Comparison

Comparables:
GILD
AMGN
VRTX
REGN
SGEN

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Abbvie Inc
NYSE:ABBV
Cash Equivalents
$12.8B
CAGR 3-Years
15%
CAGR 5-Years
12%
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Cash Equivalents
$8.4B
CAGR 3-Years
12%
CAGR 5-Years
-14%
CAGR 10-Years
15%
Amgen Inc
NASDAQ:AMGN
Cash Equivalents
$10.9B
CAGR 3-Years
20%
CAGR 5-Years
10%
CAGR 10-Years
11%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash Equivalents
$11.2B
CAGR 3-Years
23%
CAGR 5-Years
33%
CAGR 10-Years
35%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash Equivalents
$16.2B
CAGR 3-Years
95%
CAGR 5-Years
62%
CAGR 10-Years
41%
Seagen Inc
NASDAQ:SGEN
Cash Equivalents
$428.6m
CAGR 3-Years
-22%
CAGR 5-Years
30%
CAGR 10-Years
14%

See Also

What is Abbvie Inc's Cash Equivalents?
Cash Equivalents
12.8B USD

Based on the financial report for Dec 31, 2023, Abbvie Inc's Cash Equivalents amounts to 12.8B USD.

What is Abbvie Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
3%

Over the last year, the Cash Equivalents growth was 39%. The average annual Cash Equivalents growth rates for Abbvie Inc have been 15% over the past three years , 12% over the past five years , and 3% over the past ten years .